| Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains C Benito, E Núñez, RM Tolón, EJ Carrier, A Rábano, CJ Hillard, J Romero Journal of Neuroscience 23 (35), 11136-11141, 2003 | 774 | 2003 |
| Pharmacological and biochemical interactions between opioids and cannabinoids J Manzanares, J Corchero, J Romero, JJ Fernández-Ruiz, JA Ramos, ... Trends in Pharmacological Sciences 20 (7), 287-294, 1999 | 485 | 1999 |
| Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: An immunohistochemical study E Núñez, C Benito, MR Pazos, A Barbachano, O Fajardo, S González, ... Synapse 53 (4), 208-213, 2004 | 453 | 2004 |
| Cannabinoid CB2 receptor: a new target for controlling neural cell survival? J Fernández-Ruiz, J Romero, G Velasco, RM Tolón, JA Ramos, ... Trends in pharmacological sciences 28 (1), 39-45, 2007 | 452 | 2007 |
| Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity J Palazuelos, T Aguado, MR Pazos, B Julien, C Carrasco, E Resel, ... Brain 132 (11), 3152-3164, 2009 | 430 | 2009 |
| Cannabinoid CB2 receptors in human brain inflammation C Benito, RM Tolon, MR Pazos, E Nunez, AI Castillo, J Romero British journal of pharmacology 153 (2), 277-285, 2008 | 368 | 2008 |
| The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic–ischemic brain damage in mice is mediated by CB2 and adenosine receptors A Castillo, MR Tolón, J Fernández-Ruiz, J Romero, J Martinez-Orgado Neurobiology of disease 37 (2), 434-440, 2010 | 318 | 2010 |
| Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis C Benito, JP Romero, RM Tolón, D Clemente, F Docagne, CJ Hillard, ... Journal of Neuroscience 27 (9), 2396-2402, 2007 | 293 | 2007 |
| Mechanisms of cannabidiol neuroprotection in hypoxic–ischemic newborn pigs: Role of 5HT1A and CB2 receptors MR Pazos, N Mohammed, H Lafuente, M Santos, E Martínez-Pinilla, ... Neuropharmacology 71, 282-291, 2013 | 243 | 2013 |
| Activational role of cannabinoids on movement MC Sañudo-Peña, J Romero, GE Seale, JJ Fernandez-Ruiz, JM Walker European journal of pharmacology 391 (3), 269-274, 2000 | 239 | 2000 |
| Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington’s disease C Blázquez, A Chiarlone, O Sagredo, T Aguado, MR Pazos, E Resel, ... Brain 134 (1), 119-136, 2010 | 232 | 2010 |
| Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: Relevance for Huntington's disease O Sagredo, S González, I Aroyo, MR Pazos, C Benito, I Lastres‐Becker, ... Glia 57 (11), 1154-1167, 2009 | 211 | 2009 |
| Enhancement of Anandamide Formation in the Limbic Forebrain and Reduction of Endocannabinoid Contents in the Striatum of Δ9‐Tetrahydrocannabinol … V Di Marzo, F Berrendero, T Bisogno, S Gonzalez, P Cavaliere, J Romero, ... Journal of neurochemistry 74 (4), 1627-1635, 2000 | 209 | 2000 |
| The CB2 cannabinoid receptor controls myeloid progenitor trafficking involvement in the pathogenesis of an animal model of multiple sclerosis J Palazuelos, N Davoust, B Julien, E Hatterer, T Aguado, R Mechoulam, ... Journal of Biological Chemistry 283 (19), 13320-13329, 2008 | 206 | 2008 |
| Localization of mRNA expression and activation of signal transduction mechanisms for cannabinoid receptor in rat brain during fetal development F Berrendero, L Garcia-Gil, ML Hernandez, J Romero, M Cebeira, ... Development 125 (16), 3179-3188, 1998 | 198 | 1998 |
| Effects of chronic exposure to Δ9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions J Romero, E Garcia-Palomero, JG Castro, L Garcia-Gil, JA Ramos, ... Molecular brain research 46 (1-2), 100-108, 1997 | 193 | 1997 |
| A restricted population of CB1 cannabinoid receptors with neuroprotective activity A Chiarlone, L Bellocchio, C Blázquez, E Resel, E Soria-Gómez, ... Proceedings of the National Academy of Sciences 111 (22), 8257-8262, 2014 | 189 | 2014 |
| A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis C Benito, WK Kim, I Chavarría, CJ Hillard, K Mackie, RM Tolón, K Williams, ... Journal of Neuroscience 25 (10), 2530-2536, 2005 | 185 | 2005 |
| Neuroprotective effects of the nonpsychoactive cannabinoid cannabidiol in hypoxic-ischemic newborn piglets FJ Alvarez, H Lafuente, MC Rey-Santano, VE Mielgo, E Gastiasoro, ... Pediatric research 64 (6), 653, 2008 | 183 | 2008 |
| The endogenous cannabinoid system and the basal ganglia: biochemical, pharmacological, and therapeutic aspects J Romero, I Lastres-Becker, R de Miguel, F Berrendero, JA Ramos, ... Pharmacology & therapeutics 95 (2), 137-152, 2002 | 182 | 2002 |
